Literature DB >> 12545592

Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.

Burke A Cunha1.   

Abstract

Antibiotic resistance is a potential problem around the world. Among the bacteria that cause community-acquired pneumonia (CAP), resistance in Streptococcus pneumoniae is a primary concern. Resistance can occur through genetic mutations in the bacterial strain itself or can be acquired through use of some antibiotics that have a high resistance potential. In this article, Dr Cunha explores the misperceptions about antibiotic resistance and its occurrence, as well as the most appropriate therapy for CAP in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12545592     DOI: 10.3810/pgm.2003.01.1349

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008.

Authors:  Mark I Neuman; Sarah A Ting; Ahou Meydani; Jonathan M Mansbach; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2012-05       Impact factor: 3.451

Review 2.  Moxifloxacin: a review of its use in the management of bacterial infections.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Nasopharyngeal Carriage Rate and Serotypes of Streptococcus pneumoniae and Antimicrobial Susceptibility in Healthy Korean Children Younger than 5 Years Old: Focus on Influence of Pneumococcal Conjugate Vaccination.

Authors:  Eu Kyoung Lee; Ja Kyung Jun; Ui Yoon Choi; Hyo-Jin Kwon; Kyung-Hyo Kim; Jin Han Kang
Journal:  Infect Chemother       Date:  2013-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.